Emerging Health Innovators (EHI) Initiative
ID: ARPA-H-SOL-25-118Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)
Timeline
  1. 1
    Posted Jan 6, 2025, 12:00 AM UTC
  2. 2
    Updated Mar 18, 2025, 12:00 AM UTC
  3. 3
    Due Feb 5, 2025, 7:00 PM UTC
Description

The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is seeking innovative proposals for the Emerging Health Innovators (EHI) Initiative. This initiative aims to support health technology development by inviting submissions from early-career researchers and community-based organizations, focusing on addressing specific health challenges through innovative methodologies. Proposals can receive funding of up to $350,000 per year for a maximum of three years, with a two-step evaluation process that includes a solution summary and a pitch presentation. Interested parties should contact the EHI Initiative Team at EHI@ARPA-H.gov for further details, and they must adhere to the outlined submission guidelines and deadlines as specified in the solicitation documents.

Point(s) of Contact
The EHI Initiative Team
EHI@ARPA-H.gov
Files
Title
Posted
Mar 18, 2025, 7:08 PM UTC
The solicitation ARPA-H-SOL-25-118 outlines the Emerging Health Innovators (EHI) Initiative by the Advanced Research Projects Agency for Health (ARPA-H). This initiative seeks innovative proposals from eligible entities focused on health technology development, engaging early career researchers and community innovators. The initiative features two distinct tracks: Track 1 prioritizes technology-driven innovations led by early-career investigators from U.S. research institutions, while Track 2 emphasizes community-centered technological solutions spearheaded by community-based organizations (CBOs). Proposals should address specific health challenges and showcase innovative methodologies, with a maximum funding of $350,000 per year over a maximum of three years. The submission process entails a two-step evaluation, first through a solution summary followed by a pitch presentation. Key eligibility criteria and program requirements are explicitly defined, emphasizing the need for collaboration, community engagement, and technological advancement to improve health outcomes. The document serves as a critical framework for securing federal funding to foster health innovation through rigorous selection and evaluation processes tailored to align with ARPA-H's mission.
Jan 8, 2025, 12:04 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) is announcing the Emerging Health Innovators (EHI) Initiative through solicitation ARPA-H-SOL-25-118. This initiative aims to engage community innovators and early-career investigators to develop innovative biomedical and community-driven health solutions. Proposers can submit their solutions through two specific tracks: Track 1 focuses on Technology-Driven Innovation for biomedical research, while Track 2 emphasizes Community-Centered Innovation that addresses community health issues. The initiative has a timeline that includes a Proposers’ Day, a deadline for solution summaries, and proposed pitch presentation dates, leading to the selection and potential award of grants. Awards will be capped at $350,000 per year for two years, with an optional extension. Eligibility requirements differ across tracks, aiming to empower early-career researchers in Track 1 and community innovators in Track 2. Proposals will be evaluated based on scientific merit, potential impact, and cost analysis. Selected performers will engage in collaborative efforts with ARPA-H throughout the grant period, adhering to a structured submission and evaluation process. This initiative aligns with ARPA-H's mission to accelerate health innovation by fostering diverse expertise and solutions.
Mar 18, 2025, 7:08 PM UTC
The EHI Pitch document provides comprehensive guidelines for submitting proposals under the ARPA-H technology-driven innovation initiative. It outlines the structure, evaluation criteria, and expectations for proposers participating in virtual pitches. Each submission includes a project summary highlighting key technical challenges, innovative technologies, and the project's goals. The document emphasizes the importance of articulating the current solutions, gaps in research, and potential impacts on affected populations if successful. Proposers must detail their management plans, personnel qualifications, and capabilities, necessitating a clear organization and commitment from key team members. The plan must also include a Statement of Work (SOW) outlining tasks, milestones, and a timeline for the project's duration, along with a detailed cost breakdown. Moreover, the document seeks to ensure a credible plan addressing technical challenges, risk mitigation, and potential plans for commercialization. By adhering to these guidelines, applicants are expected to demonstrate their project’s merit and alignment with ARPA-H's mission, ultimately contributing to advancements in health-related technologies.
Mar 18, 2025, 7:08 PM UTC
The EHI Pitch document outlines the submission guidelines for project proposals under the ARPA-H's Track 2 Community-Centered Innovation initiative. It specifies that EHI pitches are virtual and consist of a 60-minute format comprising a 40-minute presentation followed by 20 minutes for Q&A. Evaluation criteria focus on technical merit, community impact, relevance to ARPA-H's mission, and cost assessment. The document emphasizes the importance of innovative approaches to addressing existing gaps in solutions and the need for engaging community stakeholders. Proposals must include a comprehensive analysis of technical challenges, community engagement, a management plan detailing personnel qualifications, a statement of work with milestones, and a cost breakdown for each project year. It concludes with a reminder to highlight the unique aspects of the solution, the expected impact, and the contributions from EHI and ARPA-H in the success of the proposal. This document serves as a critical guide for applicants seeking federal support for innovative projects that aim to enhance community health and wellbeing.
Mar 18, 2025, 7:08 PM UTC
The document serves as a guidelines spreadsheet for proposers participating in a government Request for Proposal (RFP) process, aimed at assisting in the preparation of cost proposals for awarded contracts, specifically related to phases of project-based funding. Key requirements include detailed cost breakdowns for direct labor, subproposers, consultant fees, and miscellaneous costs across multiple periods. Proposers must summarize costs in categories such as Direct Labor, Fringe Benefits, Labor Overhead, and General & Administrative expenses, ensuring each category ties back to the total cost. The instructions emphasize the need for accuracy and justification of proposed costs, encouraging proposers to provide a clear rationale to support their financial projections and to use set templates effectively without altering embedded formulas. Each section requires specification of project phases and a complete account of resources, thus promoting transparency and a structured approach to federal funding requests. The document ultimately establishes a framework for evaluating cost proposals to expedite the review and award process within the government contracting framework.
The Administrative and National Policy Requirements document provides essential guidelines for organizations submitting proposals to ARPA-H, a governmental entity. It outlines the format, submission requirements, and necessary disclosures related to organizational conflicts of interest, research security, human and animal subject involvement, intellectual property, and cybersecurity. Key components include: 1. **Conflict of Interest (OCI)**: Proposers must affirm if team members have affiliations that could lead to potential conflicts and provide mitigation plans if applicable. 2. **Research Security**: Proposals require disclosure of other support and affiliations, particularly concerning foreign government-sponsored recruitment programs. 3. **Intellectual Property (IP)**: Proposers must assert any IP restrictions on deliverables and provide documentation for any patented inventions used in the project. 4. **Human and Animal Subjects Research**: Evidence of IRB review and IACUC approval must be provided if the proposed work involves human or animal research. 5. **Cybersecurity**: Organizations must describe their cybersecurity practices, especially in managing Controlled Unclassified Information (CUI). Overall, the document emphasizes transparency and compliance with legal standards for ensuring integrity in government-funded research and development efforts.
The Administrative & National Policy Requirements Document outlines essential guidelines for proposal submissions as part of the federal grant process. Key requirements include formatting specifications, necessary disclosures regarding organizational conflicts of interest (OCI), and completion of various forms, such as the SF-424 (R&R) Application for Federal Assistance. Proposers must affirmatively declare any conflicts related to systems engineering support provided to ARPA-H and detail potential foreign participation or commitments. The document emphasizes compliance with research security, intellectual property rights, and stipulates strict requirements for human and animal subject research, including necessary institutional approvals. It mandates certification of compliance with non-discrimination and research integrity regulations, along with an assurance of a robust cybersecurity program for managing sensitive data. Proposers are also required to disclose any lobbying activities and provide assurances of compliance with various federal regulations. Overall, this document establishes a comprehensive framework for evaluating proposals, ensuring accountability, transparency, and adherence to legal standards in federal funding allocations.
Lifecycle
Title
Type
Solicitation
Similar Opportunities
Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003, which focuses on innovative research to enhance public health preparedness against various biomedical threats. The initiative encompasses multiple Areas of Interest (AOIs), including the development of medical countermeasures for emerging infectious diseases, repurposing existing drugs for chemical threats, and advancing technologies for at-home diagnostics. Interested parties must have active registration with SAM.gov and are encouraged to engage in pre-submission consultations; abstract submissions are due by specified deadlines, with funding amounts contingent on the quality of proposals and alignment with program goals. For further inquiries, interested vendors can contact the BARDA DCMA DRIVe Team at DRIVeAcquisitions@hhs.gov.
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
Buyer not available
Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program - Fiscal Year 2026
Buyer not available
The National Cancer Institute (NCI) within the Department of Health and Human Services is soliciting proposals for the Small Business Innovation Research (SBIR) Innovative Concept Award Program for Fiscal Year 2026. This program aims to support small businesses in developing transformative technologies for the treatment and prevention of pediatric and rare cancers, particularly those with a 5-year survival rate below 50%. Proposals must demonstrate technical feasibility and include a clear development path, addressing specific clinical problems and cancer types, while also enhancing entrepreneurship skills and commercialization strategies. Interested applicants should submit preliminary white papers by June 4, 2025, with full proposals due by September 26, 2025. The initial funding amount for the Concept Award is $300,000, and applicants can contact Tanya Renwick at ncioasbir@mail.nih.gov for further information.
Advanced Research Concepts (ARC)
Buyer not available
The Department of Defense, through the Defense Advanced Research Projects Agency (DARPA), is soliciting proposals for the Advanced Research Concepts (ARC) program, aimed at exploring high-risk, high-reward research initiatives that support U.S. national security. Proposers are required to submit concise abstracts summarizing innovative technical ideas for projects that can be executed over a 12-month period with a budget not exceeding $300,000, engaging one Full-Time Equivalent (FTE). This initiative is critical for fostering disruptive technological advancements that can significantly impact defense capabilities. Interested parties must adhere to specific submission guidelines and contact the BAA Coordinator at Innovation@darpa.mil for further information, with the solicitation remaining open for one year.
RRPV Solicitation Summary: Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the establishment of a Central Influenza and Emerging Infectious Diseases Vaccine Immunoassay Laboratory. This initiative aims to enhance national health security by facilitating the rapid development of vaccines in response to potential pandemics, with a focus on conducting immunoassays to support vaccine research and clinical trials. The successful offeror will play a critical role in strengthening biodefense infrastructure by providing standardized laboratory services, with proposals due by May 30, 2025, and questions accepted until April 24, 2025. Interested parties can contact Rebecca Harmon at rebecca.harmon@ati.org for further information.
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.
Pharmacogenomics (PGx) Testing for Military Readiness Pilot
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for a pilot program focused on pharmacogenomics (PGx) testing to enhance military readiness and healthcare delivery for Active-Duty service members. The initiative aims to establish standardized processes for routine PGx testing within the Military Health System (MHS), leveraging electronic health record (EHR) data to improve clinical decision-making and treatment outcomes. This program is critical for optimizing medication safety and efficacy, ultimately preventing adverse drug reactions and improving overall health conditions for military personnel. Interested parties should contact Dr. Lauren Palestrini at lauren.palestrini@mtec-sc.org, with a funding availability of $2.2 million and a project duration of up to 36 months. The Request for Project Proposals (RPP) is expected to be released soon, with a proposal preparation period of approximately 30 days.